AstraZeneca-Amgen Asthma Drug Gets U.S. FDA Approval

The U.S. Food and Drug Administration approved AstraZeneca and Amgen Inc’s drug, Tezspire, to treat severe asthma for those aged 12 years and older, the companies said on Friday. Read More